Sign Up for a Free Account
  • Updated 05.10.2020
  • Released 04.02.2002
  • Expires For CME 05.10.2023

Myotonic muscular dystrophy (neonatal)

Introduction

This article includes discussion of myotonic muscular dystrophy (neonatal), congenital myotonic dystrophy, dystrophia myotonica of the newborn, and infantile myotonic dystrophy. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.

Overview

Congenital myotonic dystrophy is a multisystem disorder characterized by hypotonia, generalized muscle weakness, respiratory insufficiency, feeding issues, and joint contractures during infancy. It is mostly transmitted via mothers with myotonic dystrophy type 1 due to an abnormal CTG repeat expansion of the DMPK gene on chromosome 19q13. In this article, the author reviews the clinical features of children with congenital myotonic dystrophy type 1. The extramuscular manifestations, including cardiac arrhythmias, cognitive impairment, communication problems, and maladaptive behaviors, are important challenges for the affected individuals and their caregivers. Despite the severe disease phenotype, children who survive beyond the infancy period generally experience an improvement in motor function, with stable cognitive abilities during childhood.

Key points

• Myotonic dystrophy type 1 is an autosomal dominant disorder due to abnormal expansion of trinucleotide repeats in the DMPK gene on chromosome 19q13.3.

• The severe neonatal form of myotonic dystrophy type 1 is usually associated with 1000 or more CTG repeats, with the mother being the affected parent in the majority of cases.

• Infants with the severe neonatal form of myotonic dystrophy type 1 present with hypotonia, generalized weakness, respiratory insufficiency, and feeding difficulties at birth.

• Other potential long-term complications include developmental delay, learning disabilities, behavioral problems, and cognitive impairment.

• A multidisciplinary team approach is needed to address the supportive needs of affected children and their families.

Historical note and terminology

In 1901 a rare, severe neonatal form of the already recognized disease of myotonic muscular dystrophy was first described by Gardiner (33). The clinical presentation was better defined in the 1960s and 1970s by several authors and was distinguished from the more common, slowly progressive disease of the older child and adult, though occurring in the same families (75; 19; 60; 78; 07; 21; 09; 36; 68; 63). Harper pointed out that in 94% of affected neonates of both sexes, the mother was the transmitting parent despite autosomal dominant inheritance that theoretically should not be gender-specific. Additional genetic studies in the early 1990s clarified the reason as a large number of trinucleotide repeats in the defective gene of type 1 myotonic dystrophy.

Start a MedLink Neurology trial
to unlock 3 free articles.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com